Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05022147

Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease

ENGAGE-PD: Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease

Status
Active Not Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
James Liao · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess how alternating-frequency Deep Brain Stimulation (DBS) works to improve postural instability and gait, while also treating other motor symptoms of Parkinson Disease (PD).

Detailed description

Postural instability, gait impairment, and falls are among the greatest unmet needs in Parkinson disease (PD). A single fall can be catastrophic, and impairments that limit mobility lead to social isolation or depression, and adversely affect bone and cardiovascular health. Unfortunately, postural instability and gait disorders are refractory to current pharmacological and surgical treatments, including deep brain stimulation (DBS). This project will directly address this pressing need. We will recruit participants to perform a gait task, using a new, alternating DBS frequency paradigm, while body movements and neural signals are recorded. The findings will lead to improved therapies to address these symptoms in the future.

Conditions

Interventions

TypeNameDescription
DEVICEHigh-Frequency-Only StimulationControl condition, constant high-frequency DBS stimulation (130Hz)
DEVICELow-Frequency-Only StimulationExperimental condition, constant low-frequency DBS stimulation (60 Hz)
DEVICEAlternating, 50 sec High-Frequency, 10 sec Low-Frequency StimulationExperimental condition where stimulation frequency is changed from high (130Hz) to low (60Hz) frequency. The time interval for each frequency is 50 seconds for high, and 10 seconds for low, respectively.
DEVICEAlternating, 50 sec High-Frequency, 50 sec Low-Frequency StimulationExperimental condition where stimulation frequency is changed from high (130Hz) to low (60Hz) frequency. The time interval for each frequency is 50 seconds for high, and 50 seconds for low, respectively.
DEVICEAlternating, 10 sec High-Frequency, 50 sec Low-Frequency StimulationExperimental condition where stimulation frequency is changed from high (130Hz) to low (60Hz) frequency. The time interval for each frequency is 10 seconds for high, and 50 seconds for low, respectively.
DEVICEAlternating, 10 sec High-Frequency, 10 sec Low-Frequency StimulationExperimental condition where stimulation frequency is changed from high (130Hz) to low (60Hz) frequency. The time interval for each frequency is 10 seconds for high, and 10 seconds for low, respectively.
DRUGOFF Dopaminergic MedicationAll six device interventions will be performed in medication OFF state
DRUGON Dopaminergic MedicationAll six device interventions will be performed in medication ON state

Timeline

Start date
2021-10-04
Primary completion
2024-11-15
Completion
2026-05-01
First posted
2021-08-26
Last updated
2026-01-13

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05022147. Inclusion in this directory is not an endorsement.